|
End-of-day quote
Taipei Exchange
2026-10-29
|
5-day change | 1st Jan Change | ||
| 103.50 TWD | -0.48% |
|
-9.61% | +268.33% |
| 08-13 | CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-23 | CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 22.15B 680M 609M 562M 508M 950M 64.72B 966M 6.7B 2.67B 33.87B 2.55B 2.5B 107B | P/E 2024 |
-51.9x | P/E 2025 | -20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 20.1B 617M 553M 510M 461M 863M 58.74B 877M 6.08B 2.43B 30.74B 2.32B 2.27B 97.37B | EV / Sales 2024 |
2,426x | EV / Sales 2025 | 2,773x |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.48% | ||
| 1 week | -9.61% | ||
| Current month | -14.81% | ||
| 1 month | -0.96% | ||
| 3 months | -16.19% | ||
| 6 months | +91.67% | ||
| Current year | +268.33% |
| 1 week | 101.5 |  | 109 |
| 1 month | 101.5 | | 127 |
| Current year | 22.75 | | 148.5 |
| 1 year | 22.75 | | 148.5 |
| 3 years | 22.75 | | 148.5 |
| 5 years | 22.75 | | 251.5 |
| 10 years | 12.9 | | 251.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tsung I Wu
CEO | Chief Executive Officer | - | 2022-06-22 |
Yi Pei Chou
DFI | Director of Finance/CFO | - | 2016-03-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2013-05-26 | |
| Director/Board Member | - | 2016-11-20 | |
Chao-Long Chen
CHM | Chairman | - | 2017-12-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | -9.61% | +191.96% | +29.38% | 686M | |
| +6.63% | +8.10% | +67.50% | +145.20% | 1,148B | |
| +1.53% | +6.76% | +47.22% | +89.01% | 652B | |
| +1.68% | +2.10% | +27.80% | +109.31% | 505B | |
| +0.73% | +2.47% | +53.85% | +68.96% | 384B | |
| +3.83% | -2.37% | +68.14% | +42.32% | 348B | |
| +2.38% | +4.27% | +33.81% | +57.95% | 294B | |
| +2.26% | +3.47% | +5.21% | +28.92% | 264B | |
| +1.97% | +5.11% | +57.74% | +76.14% | 244B | |
| +4.03% | +7.84% | +40.49% | +116.14% | 197B | |
| Average | +2.82% | +0.29% | +59.37% | +76.33% | 403.78B | |
| Weighted average by Cap. | +3.80% | +1.50% | +49.60% | +95.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.58M 110K 98.39K 90.77K 82.14K 154K 10.46M 156K 1.08M 432K 5.47M 412K 403K 17.34M | 1.43M 43.91K 39.33K 36.28K 32.83K 61.4K 4.18M 62.39K 433K 173K 2.19M 165K 161K 6.93M |
| Net income | -212M -6.51M -5.83M -5.38M -4.87M -9.11M -620M -9.25M -64.2M -25.61M -325M -24.44M -23.92M -1.03B | -290M -8.9M -7.97M -7.35M -6.65M -12.44M -847M -12.64M -87.73M -35M -443M -33.39M -32.68M -1.4B |
| Net Debt | -2.34B -71.71M -64.23M -59.25M -53.62M -100M -6.83B -102M -707M -282M -3.57B -269M -263M -11.32B | -2.05B -62.76M -56.22M -51.86M -46.93M -87.76M -5.98B -89.18M -619M -247M -3.13B -236M -231M -9.91B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | NT$103.50 | -0.48% | 186,077 |
| 26-10-28 | NT$104.00 | -0.95% | 304,276 |
| 26-10-27 | NT$105.00 | -2.33% | 332,976 |
| 26-10-22 | NT$107.50 | -6.11% | 576,201 |
| 26-10-21 | NT$114.50 | +10.10% | 780,607 |
- Stock Market
- Stocks
- 6586 Stock
Select your edition
All financial news and data tailored to specific country editions
